BLFS and CYRX Related Headlines
Go Back- KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
- KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'
- KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'

